
Keywords: Breast cancer; Necrosis; Apoptosis; Cytotoxicity; Cancer therapeutics; HMA; 5-(N,N-hexamethylene) amiloride; DCFH-DA; carboxy-2â²,7â²-dichloro-dihydro-fluorescein diacetate; ROS; reactive oxygen species; PI3K; phosphatidylinositol-3 kinase; PKB; protein